What was the value and size of IMAX's Q2 2026 share repurchase?

IMAX repurchased 404,866 common shares at an average price of $33.91 per share for a total of $13.7 million (excluding commissions) during the second quarter of 2026. This was the company's first repurchase activity since the Board approved the program extension in June 2025.

How much authorization does IMAX have remaining for future share buybacks?

As of June 30, 2026, IMAX had approximately $237.0 million remaining under its $500.0 million total share repurchase authorization. The company's Board approved a $100.0 million increase to the program in June 2025 and extended it through June 30, 2026.

What is the impact of IMAX's buyback activity on its share count and per-share metrics?

The Q2 2026 repurchases contributed to a slight 2% decline in basic shares outstanding year-over-year, bringing the count to 55.0 million shares. By reducing share count, buybacks mechanically support per-share earnings growth—IMAX reported diluted EPS of $0.27 in Q2 2026 (up 35% year-over-year) and adjusted diluted EPS of $0.43 (up 65% year-over-year).

Under what authorization and mechanism does IMAX conduct its share repurchases?

IMAX executes share repurchases under open-market purchase mechanisms consistent with Rule 10b-18 guidelines, which allows companies to repurchase shares during trading windows while complying with regulatory safe harbors. The program was most recently extended through June 30, 2026.

IMAX 8-K Filed 2026-07-23 Amendment

IMAX extends share repurchase program by $100M; repurchases 405K shares in Q2

Board approved $100M increase in June 2025; company had $237M remaining authorization as of quarter-end.

Remaining$237M

MechanismRule 10b-18 open-market purcha

What the filing says

IMAX Corporation repurchased 404,866 common shares at an average price of $33.91 per share during the second quarter of 2026, expending $13.7 million in total. This marks the company's first share repurchase activity since the Board of Directors approved an extension and $100.0 million increase to its share repurchase program in June 2025.

As of June 30, 2026, IMAX's total share repurchase authority stood at $500.0 million, with $237.0 million remaining available for future repurchases. The company executed its Q2 2026 repurchases under open-market purchase mechanisms consistent with Rule 10b-18 guidelines.

The repurchase activity occurred amid strong financial performance, with IMAX reporting second-quarter revenues of $102.8 million (up 12% year-over-year), net income of $15.9 million, and adjusted EBITDA of $48.0 million. The company's available liquidity as of quarter-end totaled $551 million, including $160 million in cash and $334 million in available borrowing capacity under its revolving credit facility.

In June 2025, the Company's Board of Directors approved an extension of its share repurchase program through June 30, 2026 and an increase of approximately $100.0 million in the Company's share repurchase program. As of June 30, 2026, the Company's total share repurchase authority was $500.0 million with approximately $237.0 million available under the program. — IMAX CORP 8-K filing · View on SEC EDGAR →

What this means

IMAX's Q2 2026 share repurchases and the $100 million authorization extension approved in June 2025 represent a capital allocation decision to return cash to shareholders while maintaining operational flexibility. With $237 million remaining under authorization and $551 million in total available liquidity, the company signals confidence in its business momentum, highlighted by record box office performance from Christopher Nolan's "The Odyssey." The repurchase reduces share count—basic shares outstanding declined 2% year-over-year to 55.0 million—which supports per-share earnings growth independent of operational performance, though the buyback's impact remains modest relative to IMAX's market activity and cash generation profile.

Frequently asked questions

What was the value and size of IMAX's Q2 2026 share repurchase?: IMAX repurchased 404,866 common shares at an average price of $33.91 per share for a total of $13.7 million (excluding commissions) during the second quarter of 2026. This was the company's first repurchase activity since the Board approved the program extension in June 2025.
How much authorization does IMAX have remaining for future share buybacks?: As of June 30, 2026, IMAX had approximately $237.0 million remaining under its $500.0 million total share repurchase authorization. The company's Board approved a $100.0 million increase to the program in June 2025 and extended it through June 30, 2026.
How do IMAX's share buybacks fit within its overall capital structure and liquidity position?: IMAX's repurchase activity occurs within a strong liquidity context: the company reported $551 million in available liquidity as of June 30, 2026, including $160 million in cash and $334 million in available revolving credit. Share repurchases represent one element of capital allocation alongside debt management and operational investments.
What is the impact of IMAX's buyback activity on its share count and per-share metrics?: The Q2 2026 repurchases contributed to a slight 2% decline in basic shares outstanding year-over-year, bringing the count to 55.0 million shares. By reducing share count, buybacks mechanically support per-share earnings growth—IMAX reported diluted EPS of $0.27 in Q2 2026 (up 35% year-over-year) and adjusted diluted EPS of $0.43 (up 65% year-over-year).
Under what authorization and mechanism does IMAX conduct its share repurchases?: IMAX executes share repurchases under open-market purchase mechanisms consistent with Rule 10b-18 guidelines, which allows companies to repurchase shares during trading windows while complying with regulatory safe harbors. The program was most recently extended through June 30, 2026.

amendment execution rule-10b-18 mega-cap entertainment-sector capital-return

Source. This editorial summary is based on the SEC filing linked above. BuybackStocks aggregates and editorializes publicly available SEC EDGAR filings. Not investment advice. Past authorization announcements do not guarantee future repurchase activity or share price performance. See our full disclosures policy.